English: A map to show the global prevalence of Fasciola hepatica. The red countries are those with a high prevalence of the parasite, the orange are those with a low-medium prevalence. (Map created based on data from[1][2][3][4])
↑ (2005). "Epidemiology of fascioliasis in human endemic areas". Journal of Helminthology79 (3): 207–216. DOI:10.1079/JOH2005296. ISSN0022149X.
↑Cywińska A (2005). "Epidemiology of fascioliasis in human endemic areas.". Journal of helminthology79 (3): 207–216. DOI:10.1079/JOH2005296.
↑Tolan RW (2011). "Fascioliasis due to Fasciola hepatica and Fasciola gigantica infection: an update on this ‘neglected’neglected tropical disease.". Laboratory Medicine42 (2): 107–116. DOI:10.1309/LMLFBB8PW4SA0YJI.
↑ (2007). "Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica". Parasitology133 (S2): S43. DOI:10.1017/S0031182006001806. ISSN0031-1820.